As complement gene defects and the ARMS2/HTRA1 risk haplotype contribute differently to AMD pathogenesis, it is expected that the presence of both would lead to a significant interaction on disease risk (Table 6), although our sensitivity analyses show that this association may not be robust to genetic confounding. This evidence concerns the gene ARMS2 and age-related macular degeneration.